Jasinski Lawrence J

SEC Form 4 insider trading activity

Jasinski Lawrence J has filed 6 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: May 11, 2026.

On the most recent filing, Jasinski Lawrence J is listed as Director at LEMAITRE VASCULAR INC. Inside the rolling window, Jasinski Lawrence J reported no open-market purchases and 1 open-market sale totaling $434K in LMAT.

Companies traded

Other insiders at LMAT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$434K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LMATSale$434KMay 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Jasinski Lawrence J made?

Jasinski Lawrence J has filed 6 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.

Which companies does Jasinski Lawrence J trade?

Jasinski Lawrence J has filed SEC Form 4 disclosures for 1 company, including LMAT.

When was Jasinski Lawrence J's most recent SEC Form 4 filing?

Jasinski Lawrence J's most recent SEC Form 4 filing on Tracefour is dated May 11, 2026.

What is Jasinski Lawrence J's total buy and sell value in the current window?

Inside the rolling retention window, Jasinski Lawrence J bought $0 and sold $434K based on SEC Form 4 filings.

What was Jasinski Lawrence J's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 3,943 LMAT shares on 2026-05-07, worth $434K, per SEC Form 4 filings.